Improving the value of your US patent portfolio: lessons for Australian and NZ companies from the decision of Bard v Gore
By EsqSocial Corporation 23/07/14
Recent developments in US law have meant that investors conducting due diligence of biotech and technology companies now not only consider whether the company’s US patents are valid and cover the relevant technology but also the manner in which the...
By: Freehills Patent Attorneys